Lisata Therapeutics, Inc. (LSTA) Capital expenditures 2015–2024
Lisata Therapeutics, Inc. (LSTA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$28,000FY2024 · since FY2015: $1.1M → $28,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $28,000 | — |
| FY2023 | $0 | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $285,000 | +375.0% |
| FY2020 | $60,000 | +200.0% |
| FY2019 | $20,000 | — |
| FY2018 | $0 | -100.0% |
| FY2017 | $134,000 | -0.7% |
| FY2016 | $135,000 | -87.7% |
| FY2015 | $1.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice